Plus de 40 ans d’expérience à votre service

Tel. : 01 45 33 67 17 / E-mail : coger@coger.fr

Stock épuisé.
En rupture de stock
Quantité minimum d'achat
La quantité minimum d'achat n'est pas atteinte

 

 

5 mg

Ref. SYN-1097-M005
SYNKINASE
492445-28-0

photos non contractuelles

Neuf 515.00 H.T.

Quantité

Alerte réapprovisionnement
Recevez une alerte par email dès que votre choix sera de retour en stock
Votre e-mail*:

Détails Produit

Chemical. C17H21N3O2S. CAS: 492445-28-0. MW: 331.4. Cyclin-dependent kinases (CDKs) are key regulators of cell progression. CDK2 and CDK4 are responsible for phosphorylation of the Retinoblastoma (RB) protein causing activation of the E2F transcription factor and transcription of genes involved in the G1/S transition and initiation of DNA replication. Several CDK inhibitors are thus being developed as potential anti-cancer agents. PHA-690509 on such CDK inhibitor. PHA-690509 is a ATP-competitive CDK inhibitor with submicromolar IC(50) against multiple CDKs, in particular CDK2, its primary target (IC(50) 31nM). In cell proliferation assays, PHA-690509 demonstrated marked potency against several cells lines with IC(50) values in the submicromolar range primarily.

Lien vers la fiche technique